Psilocybin Assisted-Psychotherapy
Many public and commercial psychedelic enterprises are working on producing synthetic and mushroom drugs, and an increasing number of them are interested in psychedelic-assisted therapy.
The availability of psilocybin-assisted therapy will increase as a result of these improvements, though the cost barriers to entry are not yet established. However, psilocybin-assisted treatment may soon gain acceptance as a legitimate subfield of psychotherapy.
Intake of psilocybin is a component of psilocybin-assisted therapy, which aims to promote healing and transformation while exploring a particular, predetermined intention. The three separate therapy phases of preparation, the acute psychedelic experience, and integration are frequently mentioned by researchers and physicians. The non-psychedelic components of this strategy are critical to its efficacy and security.
Typically, there is a preparation phase in which the patient and therapist get to know one another, and form a trusting relationship.
During the session, the patient lies down in a specially designed room, with a comfortable bed or mat. They should feel at ease in the environment
Often, a specially curated music playlist will be listened to which is designed to heighten the inward journey, while wearing a comfortable eye mask, similar to one for sleeping.
Most patients begin to feel the significant effects approximately 30-45 minutes after receiving their dose, which typically lasts for 3-4 hours, followed by 1-2 hours of “come down”. A trained therapist remains present at all times throughout this session.
Following this time, sometimes referred to as a “journey”, patients are encouraged to discuss their experience. With guidance from their therapist, the goal is to identify insights that may create lasting positive change with emotional or behavioral patterns.
Image/Info Provided By MindMedicineAustralia.org.au,https://www.psilocybin.org/